Prevalencia y presentación clínica | 04 ABR 23

COVID prolongado en niños

Metaanálisis sobre la prevalencia y la presentación clínica del COVID prolongado en niños.
Autor/a: Roberta Pellegrino, Elena Chiappini, Amelia Licari, Luisa Galli, Gian Luigi Marseglia  European Journal of Pediatrics (2022) 181:39954009
INDICE:  1. Texto principal | 2. Referencias bibliográficas
Referencias bibliográficas

1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (2020) The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5:536–544. https://doi.org/10. 1038/s41564-020-0695-z

2. Lopez-Leon S, Wegman-Ostrosky T, Perelman C et al (2021) More than 50 long-term efects of COVID-19: a systematic review and meta-analysis. Sci Rep 11:16144. https://doi.org/10.1038/ s41598-021-95565-8

3. National Istitute for Health and Care Excellence (2020) COVID19 rapid guideline: managing the long-term efects of COVID-19. http://www.ncbi.nlm.nih.gov/books/NBK567261. Accessed 9 Oct 2021

4. CDC (2020) Healthcare workers. In: Cent. Dis. Control Prev. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/ post-covid-conditions.html. Accessed 9 Oct 2021

5. Soriano JB, Murthy S, Marshall JC et al (2021) A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(21) 00703-9

6. Stephenson T, Allin B, Nugawela MD et al (2022) Long COVID (post-COVID-19 condition) in children: a modifed Delphi process. Arch Dis Child 107:674–680. https://doi.org/10.1136/ archdischild-2021-323624

7. Galindo R, Chow H, Rongkavilit C (2021) COVID-19 in children. Pediatr Clin North Am 68:961–976. https://doi.org/10.1016/j.pcl. 2021.05.004

8. Henderson LA, Canna SW, Friedman KG et al (2021) American College of Rheumatology clinical guidance for multisystem infammatory syndrome in children associated with SARS-CoV-2 and hyperinfammation in pediatric COVID-19: version 2. Arthritis Rheumatol Hoboken NJ 73:e13–e29. https://doi.org/10.1002/ art.41616

9. The BMJ (2020) Counting long covid in children. https://blogs. bmj.com/bmj/2020/10/16/counting-long-covid-in-children/. Accessed 10 Oct 2021

10. Ludvigsson JF (2021) Case report and systematic review suggest that children may experience similar long-term efects to adults after clinical COVID-19. Acta Paediatr 110:914–921. https://doi. org/10.1111/apa.15673

11. Zimmermann P, Pittet LF, Curtis N (2021) How common is long COVID in children and adolescents? Pediatr Infect Dis J 40:e482– e487. https://doi.org/10.1097/INF.0000000000003328

12. Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71

13. Say D, Crawford N, McNab S et al (2021) Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc Health 5:e22–e23. https://doi.org/10.1016/S2352- 4642(21)00124-3

14. Sterky E, Olsson-Åkefeldt S, Hertting O et al (1992) (2021) Persistent symptoms in Swedish children after hospitalisation due to COVID-19. Acta Paediatr Oslo Nor 110:2578–2580. https://doi. org/10.1111/apa.15999

15. von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. The Lancet 370:1453–1457. https://doi.org/10.1016/S0140- 6736(07)61602-X

16. Munn Z, Barker TH, Moola S et al (2020) Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth 18:2127–2133. https://doi.org/10.11124/ JBISRIR-D-19-00099

17. Ashkenazi-Hoffnung L, Shmueli E, Ehrlich S et al (2021) Long COVID in children: observations from a designated pediatric clinic. Pediatr Infect Dis J. https://doi.org/10.1097/ INF.0000000000003285

18. Radtke T, Ulyte A, Puhan MA, Kriemler S (2021) Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. https://doi.org/10.1001/jama.2021.11880

19. Molteni E, Sudre CH, Canas LS et al (2021) Illness duration and symptom profle in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health 5:708–718. https://doi.org/10.1016/S2352-4642(21)00198-X

20. Miller F, Nguyen V, Navaratnam AM et al (2021) Prevalence of persistent symptoms in children during the COVID-19 pandemic: evidence from a household cohort study in England and Wales. Pediatrics. https://doi.org/10.1101/2021.05.28.21257602. Accessed9October2021

21. Osmanov IM, Spiridonova E, Bobkova P et al (2021) Risk factors for long COVID in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J 59:2101341. https://doi.org/10.1183/13993003. 01341-2021

22. Stephenson T, Pereira SMP, Shafran R et al (2022) Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health. https://doi. org/10.1016/S2352-4642(22)00022-0

23. Smane L, Roge I, Pucuka Z, Pavare J (2021) Clinical features of pediatric post-acute COVID-19: a descriptive retrospective follow-up study. Ital J Pediatr 47:177. https://doi.org/10.1186/ s13052-021-01127-z

24. Borch L, Holm M, Knudsen M et  al (2022) Long COVID symptoms and duration in SARS-CoV-2 positive children – a nationwide cohort study. Eur J Pediatr. https://doi.org/10.1007/ s00431-021-04345-z

25. Heching HJ, Goyal A, Harvey B et al (2022) Electrocardiographic changes in non-hospitalised children with COVID-19. Cardiol Young. https://doi.org/10.1017/S1047951121005138

26. Roge I, Smane L, Kivite-Urtane A et al (2021) Comparison of persistent symptoms after COVID-19 and other non-SARS-CoV-2 infections in children. Front Pediatr 9:752385. https://doi.org/10. 3389/fped.2021.752385

27. Buonsenso D, Munblit D, De Rose C et al (2021) Preliminary evidence on long COVID in children. Acta Paediatr 110:2208–2211. https://doi.org/10.1111/apa.15870

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024